In vitro activity of ramoplanin and comparator drugs against anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora
- 1 August 2004
- Vol. 10 (4) , 205-211
- https://doi.org/10.1016/j.anaerobe.2004.04.003
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Misuse of VancomycinPediatrics in Review, 2003
- In Vitro Activities of Daptomycin, Vancomycin, Quinupristin- Dalfopristin, Linezolid, and Five Other Antimicrobials against 307 Gram-Positive Anaerobic and 31 Corynebacterium Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2003
- Vancomycin, teicoplanin, and ramoplanin: Synthetic and mechanistic studies†Medicinal Research Reviews, 2001
- A New Structure for the Substrate-Binding Antibiotic RamoplaninJournal of the American Chemical Society, 2001
- In vitro activity of LY333328 (oritavancin) against Gram-positive aerobic cocci and synergy with ciprofloxacin against enterococciJournal of Antimicrobial Chemotherapy, 2001
- Limitations of presently available glycopeptides in the treatment of Gram-positive infectionClinical Microbiology & Infection, 2001
- Emergence of Vancomycin Resistance inStaphylococcus aureusNew England Journal of Medicine, 1999
- In vitro activity of ramoplanin against vancomycin-resistant gram-positive organismsAntimicrobial Agents and Chemotherapy, 1993
- Mechanisms and implications of glycopeptide resistance in enterococciThe American Journal of Medicine, 1991
- Inhibition of peptidoglycan biosynthesis by ramoplaninAntimicrobial Agents and Chemotherapy, 1990